4//SEC Filing
ESPERION THERAPEUTICS INC/MI 4
Accession 0001209191-04-009419
CIK 0001066745operating
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 7:59 PM ET
Size
8.6 KB
Accession
0001209191-04-009419
Insider Transaction Report
Form 4
MORE EILEEN M
Director
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2004-02-10−40,000→ 0 total→ Common Stock (40,000 underlying)
Footnotes (2)
- [F1]These options, with exercise prices ranging from $5.69 to $18.50, and which provided for vesting in two equal installments on September 26, 2003 and September 26, 2004 or in three equal installments on consecutive anniversaries of the date of grant, were canceled pursuant to the Agreement and Plan of Merger dated December 19, 2003, as amended on January 16, 2004, by and among Esperion Therapeutics, Inc., Enzo Aquisition Corp. and Pfizer Inc. in exchange for a cash payment representing the difference between the exercise prices of the options and the market value of the underlying common stock on the effective date of the merger ($35.00).
- [F2]The expiration dates of these options range from May 17, 2009 to September 25, 2013.
Issuer
ESPERION THERAPEUTICS INC/MI
CIK 0001066745
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001066745
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 7:59 PM ET
- Size
- 8.6 KB